Literature DB >> 9234513

Nucleic acid vaccines: an overview.

H L Robinson1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9234513     DOI： 10.1016/s0264-410x(96)00249-6

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  25 in total

1.  Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.

Authors:  Z H Huang; H Zhuang; S Lu; R H Guo; G M Xu; J Cai; W F Zhu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 3.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

4.  Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.

Authors:  Rosemary M Cook; Claudia Carvalho-Queiroz; Gregory Wilding; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Authors:  Tae Woo Kim; Jin Hyup Lee; Chien-Fu Hung; Shiwen Peng; Richard Roden; Mei-Cheng Wang; Raphael Viscidi; Ya-Chea Tsai; Liangmei He; Pei-Jer Chen; David A K Boyd; T-C Wu
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 6.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.

Authors:  Matthew D Dunn; Shannan L Rossi; Donald M Carter; Matthew R Vogt; Erin Mehlhop; Michael S Diamond; Ted M Ross
Journal:  Virol J       Date:  2010-05-12       Impact factor: 4.099

8.  Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.

Authors:  Simon R Best; Shiwen Peng; Chi-Mou Juang; Chien-Fu Hung; Drew Hannaman; John R Saunders; T-C Wu; Sara I Pai
Journal:  Vaccine       Date:  2009-07-19       Impact factor: 3.641

9.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Authors:  Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Hee-Jong Yang; Yong-Joon Chwae; Kyongmin Kim; Sun Park; Ho-Joon Shin
Journal:  Clin Vaccine Immunol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.